Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313356713> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4313356713 endingPage "69.36" @default.
- W4313356713 startingPage "69.36" @default.
- W4313356713 abstract "Abstract Immunotherapy is a promising approach for the treatment of metastatic melanoma and combination strategies may have potential for improving therapeutic responses. CTLA-4 blockade increases the CD8:Treg ratio in the tumor microenvironment and IL-2 promotes NK and CD8+ T cell function. Thus, we hypothesized combination IL-2 and CTLA-4 blockade would result in improved anti-tumor responses. This hypothesis was confirmed utilizing the poorly immunogenic B16 melanoma model, with CTLA-4 blocking antibody on days 3, 6, and 9 and/or IL-2 twice daily on days 4-8 after challenge, mirroring clinical use of these agents. Combination immunotherapy resulted in delayed tumor growth and prolonged survival compared to either monotherapy. Depletion studies suggested that both CD8+ T and NK cells were required for the therapeutic effects. In this model, combination treatment resulted in fewer tumor-infiltrating CD8+ T and NK cells but more infiltrating Tregs in the tumor microenvironment when compared to monotherapy CTLA-4 blockade. Further, IL-2 therapy was associated with a reduction in the proportion of highly differentiated/exhausted NK cells in the tumor microenvironment. No significant toxicity was observed in the mice. These results support the combination of IL-2 and CTLA-4 blockade in melanoma and a clinical trial based on these data has been initiated." @default.
- W4313356713 created "2023-01-06" @default.
- W4313356713 creator A5004415872 @default.
- W4313356713 creator A5030196328 @default.
- W4313356713 creator A5052940203 @default.
- W4313356713 creator A5054803465 @default.
- W4313356713 creator A5075350327 @default.
- W4313356713 creator A5090739964 @default.
- W4313356713 date "2015-05-01" @default.
- W4313356713 modified "2023-09-26" @default.
- W4313356713 title "NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with CTLA-4 blockade and IL-2 (TUM2P.1039)" @default.
- W4313356713 doi "https://doi.org/10.4049/jimmunol.194.supp.69.36" @default.
- W4313356713 hasPublicationYear "2015" @default.
- W4313356713 type Work @default.
- W4313356713 citedByCount "0" @default.
- W4313356713 crossrefType "journal-article" @default.
- W4313356713 hasAuthorship W4313356713A5004415872 @default.
- W4313356713 hasAuthorship W4313356713A5030196328 @default.
- W4313356713 hasAuthorship W4313356713A5052940203 @default.
- W4313356713 hasAuthorship W4313356713A5054803465 @default.
- W4313356713 hasAuthorship W4313356713A5075350327 @default.
- W4313356713 hasAuthorship W4313356713A5090739964 @default.
- W4313356713 hasConcept C126322002 @default.
- W4313356713 hasConcept C154317977 @default.
- W4313356713 hasConcept C167672396 @default.
- W4313356713 hasConcept C170493617 @default.
- W4313356713 hasConcept C202751555 @default.
- W4313356713 hasConcept C203014093 @default.
- W4313356713 hasConcept C21705690 @default.
- W4313356713 hasConcept C2776090121 @default.
- W4313356713 hasConcept C2776107976 @default.
- W4313356713 hasConcept C2776999253 @default.
- W4313356713 hasConcept C2777658100 @default.
- W4313356713 hasConcept C2777701055 @default.
- W4313356713 hasConcept C2778468042 @default.
- W4313356713 hasConcept C502942594 @default.
- W4313356713 hasConcept C55493867 @default.
- W4313356713 hasConcept C71924100 @default.
- W4313356713 hasConcept C86803240 @default.
- W4313356713 hasConcept C8891405 @default.
- W4313356713 hasConcept C98274493 @default.
- W4313356713 hasConceptScore W4313356713C126322002 @default.
- W4313356713 hasConceptScore W4313356713C154317977 @default.
- W4313356713 hasConceptScore W4313356713C167672396 @default.
- W4313356713 hasConceptScore W4313356713C170493617 @default.
- W4313356713 hasConceptScore W4313356713C202751555 @default.
- W4313356713 hasConceptScore W4313356713C203014093 @default.
- W4313356713 hasConceptScore W4313356713C21705690 @default.
- W4313356713 hasConceptScore W4313356713C2776090121 @default.
- W4313356713 hasConceptScore W4313356713C2776107976 @default.
- W4313356713 hasConceptScore W4313356713C2776999253 @default.
- W4313356713 hasConceptScore W4313356713C2777658100 @default.
- W4313356713 hasConceptScore W4313356713C2777701055 @default.
- W4313356713 hasConceptScore W4313356713C2778468042 @default.
- W4313356713 hasConceptScore W4313356713C502942594 @default.
- W4313356713 hasConceptScore W4313356713C55493867 @default.
- W4313356713 hasConceptScore W4313356713C71924100 @default.
- W4313356713 hasConceptScore W4313356713C86803240 @default.
- W4313356713 hasConceptScore W4313356713C8891405 @default.
- W4313356713 hasConceptScore W4313356713C98274493 @default.
- W4313356713 hasIssue "1_Supplement" @default.
- W4313356713 hasLocation W43133567131 @default.
- W4313356713 hasOpenAccess W4313356713 @default.
- W4313356713 hasPrimaryLocation W43133567131 @default.
- W4313356713 hasRelatedWork W1976133526 @default.
- W4313356713 hasRelatedWork W2055715607 @default.
- W4313356713 hasRelatedWork W2404290847 @default.
- W4313356713 hasRelatedWork W2782893986 @default.
- W4313356713 hasRelatedWork W2912621681 @default.
- W4313356713 hasRelatedWork W3200807512 @default.
- W4313356713 hasRelatedWork W4307607145 @default.
- W4313356713 hasRelatedWork W4312075079 @default.
- W4313356713 hasRelatedWork W4313356713 @default.
- W4313356713 hasRelatedWork W4313904512 @default.
- W4313356713 hasVolume "194" @default.
- W4313356713 isParatext "false" @default.
- W4313356713 isRetracted "false" @default.
- W4313356713 workType "article" @default.